HD17: PET guided omission of radiotherapy in Hodgkin lymphoma
1 Views
administrator
07/09/23
Peter Borchmann, MD , University Hospital Cologne, Cologne, Germany, discusses HD17 (NCT01356680), a Phase III trial of PET-guided omission of radiotherapy in early-stage unfavorable Hodgkin lymphoma patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
-
Category
Show more
Facebook Comments
No comments found